Abstract
This month's annual AMERSA (the Association for Multidisciplinary Education and Research in Substance use and Addiction) conference featured not a “spicy debate,” but a debate nonetheless, in which proponents switched sides midway. While it was clear from audience applause that the 400 or so attendees were on one “side” — the side of deregulating methadone for opioid use disorder — the Nov. 3 discussion was still important to the physician members. ADAW could not be there, but Stefan Kertesz, M.D., a professor of medicine at the University of Alabama at Birmingham, attended and posted a YouTube of the debate after obtaining permission from the speakers. Here's what Kertesz reported:
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
